Aeglea BioTherapeutics Inc. (AGLE) slipped -5.27% or -0.58 to $10.42. It is approximately 226875 shares traded, which is 71.2% compare to the average total volume 318653. The market cap of AGLE is $227.77 million. The year to date change is 99.19%. The 52 week price range is from $2.81 to $12.0. Price of AGLE have changed 4.46% during last week. It have changed 9.13% over last month, 14.35% over last 3 months, 104.46% over last 6 months and 192.55% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AGLE is 10.07. It is -3.36% below current price. The 200-day Moving Averages for AGLE is 7.21. It is -30.81% below current price. The 52-week High is 12.0. It is 15.16% from the current price. The 52-week Low is 2.81. It is -73.03% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of AGLE is 0.26 on 2018-06-15. Short % to float is 0.29%. There are some statistics of AGLE. It is has market cap $227.77 million. The share outstanding is 21.86 million. The average volume is 318653. The revenue is 2.74M. The percent of top 15 Institution holding is 45.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AGLE is -57.58%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AGLE is -52.42%.